CorMedix Inc. (FRA:19KA)
Germany
· Delayed Price · Currency is EUR 8.90
+0.20 (2.30%)
Last updated: Dec 5, 2025, 8:10 AM CET
CorMedix Company Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.
The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007.
CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CorMedix Inc.
| Country | United States |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 65 |
| CEO | Joseph Todisco |
Contact Details
Address: 300 Connell Drive Berkeley Heights, Delaware 07922 United States | |
| Phone | 908 517 9500 |
| Website | cormedix.com |
Stock Details
| Ticker Symbol | 19KA |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Joseph Todisco | Chief Executive Officer |
| Susan Blum | Chief Financial Officer |
| Elizabeth Masson-Hurlburt | Chief Operating Officer |